NCT00302354View on ClinicalTrials.gov

A Double-blind Randomized, Placebo-controlled, Crossover Study of Single Doses of OROS Methylphenidate Hydrochloride (CONCERTA) and Long-acting Methylphenidate Hydrochloride (RITALIN LA) in Healthy Adults

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions

Healthy Volunteers

Interventions

DRUG

OROS methylphenidate HCl

DRUG

SODAS methylphenidate HCl

Trial Locations (1)

02138

Massachusetts General Hospital, Cambridge

All Listed Sponsors

collaborator

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT00302354 - A Double-blind Randomized, Placebo-controlled, Crossover Study of Single Doses of OROS Methylphenidate Hydrochloride (CONCERTA) and Long-acting Methylphenidate Hydrochloride (RITALIN LA) in Healthy Adults | Biotech Hunter | Biotech Hunter